Filters close
Newswise: 1920_heart-and-veins-cedars-sinai.jpg?10000
Released: 24-Jul-2024 8:05 PM EDT
High Levels of a Specific Antibody May Contribute to Acute Coronary Syndrome
Cedars-Sinai

How a person’s immune system responds to a protein called LL-37 may increase risk for developing acute coronary syndrome, but the response may also serve as a potential target for future treatments.

Released: 24-Jul-2024 6:05 PM EDT
The National Center for School Crisis and Bereavement at Children’s Hospital Los Angeles and Save the Children Partner to Support Grieving Children
Children's Hospital Los Angeles

The National Center for School Crisis and Bereavement at Children’s Hospital Los Angeles and Save the Children are announcing a strategic partnership, designed to support grieving children throughout the United States.

Released: 24-Jul-2024 5:30 PM EDT
Sipping Alcohol in Early Adolescence May Contribute to Personality Changes and Depression
Research Society on Alcoholism

Children who try alcohol may experience mental health and personality effects as they transition to early adolescence. An analysis of alcohol sampling behavior in children ages 9 to 14, published in Alcohol: Clinical and Experimental Research, found that children who had poor response inhibition and increased alcohol sipping behaviors might be more likely to have accelerated changes in personality traits and depression scores over time. The study suggests that even minimal alcohol experimentation in early adolescence may influence later alcohol use as well as personality and mental health issues.

     
Released: 24-Jul-2024 5:05 PM EDT
Sylvester Science Contributes to Guidelines for Anal Cancer
Sylvester Comprehensive Cancer Center

Federal health officials recently released new guidelines for anal cancer screening to protect people with HIV, an achievement made possible by a landmark study conducted at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and Jackson Memorial Hospital, and other research institutions.

Released: 24-Jul-2024 5:05 PM EDT
New research discovers a new combination of therapy for people with a type of leukemia, leading them to live longer
Mayo Clinic

In a new multicenter international study led by the Mayo Clinic Comprehensive Cancer Center, researchers found that people with the B-cell precursor subtype of acute lymphoblastic leukemia (BCP-ALL), who also lacked a genetic abnormality known as the Philadelphia chromosome and were in remission with no trace of cancer, showed significantly higher survival rates when blinatumomab was added to their chemotherapy treatment.

Released: 24-Jul-2024 4:05 PM EDT
Formation of the spinal cord in the embryo: the role of a family of proteins elucidated
Universite de Montreal

The discovery of the role of β-arrestins in the formation of the spinal cord at the embryonic stage opens up perspectives for exploring the mechanisms that would allow its lesions to be repaired.

Released: 24-Jul-2024 4:05 PM EDT
Daily rhythms depend on receptor density in biological clock
Washington University in St. Louis

Tweaking the numbers of receptors in a key brain area changes the daily rhythms of rest and wake in mice, according to research from WashU, published in the Proceedings of the National Academy of Sciences.

   
Released: 24-Jul-2024 4:05 PM EDT
Nipah Virus Outbreak in India: A deadly Pathogen
Newswise

Recent reports of the Nipah virus in India have raised alarms as the country grapples with this deadly pathogen. The latest outbreak has resulted in the death of a teenager in Kerala, prompting heightened vigilance and public health responses.

19-Jul-2024 12:05 PM EDT
Does Your Body Composition Affect Your Risk of Dementia or Parkinson’s?
American Academy of Neurology (AAN)

People with high levels of body fat stored in their belly or arms may be more likely to develop diseases like Alzheimer’s and Parkinson’s than people with low levels of fat in these areas, according to a study published in the July 24, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Hackensack Meridian Jersey Shore University Medical Center Providing Patients the First Revisional, In-Stent Heart Treatment
Released: 24-Jul-2024 3:05 PM EDT
Hackensack Meridian Jersey Shore University Medical Center Providing Patients the First Revisional, In-Stent Heart Treatment
Hackensack Meridian Health

Heart care experts at Hackensack Meridian Jersey Shore University Medical Center are now providing patients with the AGENTTM Drug-Coated Balloon (DCB), designed to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease.

Newswise: ATS Urges Do-Over on House of Representatives FY25 Interior & Environment Appropriations Bill
Released: 24-Jul-2024 3:05 PM EDT
ATS Urges Do-Over on House of Representatives FY25 Interior & Environment Appropriations Bill
American Thoracic Society (ATS)

American Thoracic Society Environmental Health Policy Committee Chair Alison Lee, MD, strongly opposes proposed FY25 cuts that would jeopardize the health of all Americans: “Clean air, clean water and a healthy environment are essential to the health of all Americans. That is why I am calling on Congress to scrap the current FY25 Interior and Environment Appropriations bill and start over.

Released: 24-Jul-2024 3:05 PM EDT
حدد علماء مايو كلينك نوع جديد من فقدان الذاكرة لدى البالغين الأكبر سنًا
Mayo Clinic

روتشستر، ولاية مينيسوتا — وضع الباحثون في مايو كلينك معايير جديدة لمتلازمة فقدان الذاكرة لدى البالغين الأكبر سنًا والتي تؤثر تحديدًا على الجهاز الحوفي الدماغي، وقد يتم تشخيص هذه الحالة على سبيل الخط�� على أنها داء الزهايمر في كثير من الأحيان. الخبر السار هو أن متلازمة التنكس العصبي لفقد الذاكرة السائدة الحوفي تتفاقم بصورة أبطأ ولها تنبؤات أفضل بخصوص سَيْر المرض، كما أصبحت محددة بشكل أوضح للأطباء الذين يعملون على إيجاد إجابات لمرضى فقدان الذاكرة.

Newswise: Stroke recovery: it’s in the genes
Released: 24-Jul-2024 2:05 PM EDT
Stroke recovery: it’s in the genes
University of California, Los Angeles (UCLA), Health Sciences

New research led by UCLA Health has found that specific genes may be related to the trajectory of recovery for stroke survivors, providing doctors insights useful for developing targeted therapies.

Newswise:Video Embedded fda-changes-to-lab-tests-regulations-livestream-expert-panel
VIDEO
Released: 24-Jul-2024 1:05 PM EDT
FDA Changes to Laboratory Developed Test Regulation: Livestreamed Expert Panel
Newswise

Live from the annual conference of the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), experts will discuss how the new FDA rule on laboratory developed tests will hinder patient care. This rule will place these tests under duplicative FDA oversight, even though laboratory developed tests are already regulated by the Centers for Medicare & Medicaid Services. This will force many labs to stop performing these essential tests, which play a critical role in diagnosing rare disorders, such as inherited genetic conditions in newborns.

       
Released: 24-Jul-2024 1:05 PM EDT
Older adults want to cut back on medication, but study shows need for caution
Michigan Medicine - University of Michigan

More than 82% of Americans age 50 to 80 take one or more kinds of prescription medication, and 80% of them say they’d be open to stopping one or more of those drugs -- with major differences among people with different health conditions.

Released: 24-Jul-2024 12:45 PM EDT
bioMérieux receives US FDA 510(k) clearance for its AST System VITEK® REVEAL™
ADLM 2024 Press Program

bioMérieux, a world leader in in vitro diagnostics, today announces that its VITEK® REVEAL™ AST System, reporting results directly from positive blood cultures, has received U.S. Food and Drug Administration (FDA) 510(k) clearance.

Released: 24-Jul-2024 12:30 PM EDT
New Study Determines Incidence of and Risk Factors for Hepatitis C Virus Reinfection Among Men with HIV, Offers New Insight on Transmission
Mount Sinai Health System

A new study determines incidence of and risk factors for hepatitis C virus reinfection among men with HIV, and offers new insight on transmission.

Released: 24-Jul-2024 12:15 PM EDT
bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
ADLM 2024 Press Program

bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments).



close
0.13782